Molecular biology of lung cancer: clinical implications.
Molecular biology of lung cancer: clinical implications.
复制标题
DOI:
10.1016/j.ccm.2011.08.003
复制
发表时间:
2011-12
影响因子:
5.7
通讯作者:
Minna JD
中科院分区:
文献类型:
--
作者:
Larsen JE;Minna JD
Lung cancer is the leading cause of cancer-related death in men and women in the United States accounting for approximately 28% of total cancer deaths in 2010 despite comprising only~ 15% of new cancer cases1. Decades of research have contributed to our understanding that lung cancer is a multi-step process involving genetic and epigenetic alterations where resulting DNA damage transforms normal lung epithelial cells into lung cancer2, 3. It is not known whether all lung epithelial cells or only a subset of these cells (such as pulmonary epithelial stem cells or their immediate progenitors) are susceptible to full malignant transformation. Additionally, while the tumor initiating cell may have only a handful of mutations, as the tumor expands cells may acquire additional mutations4. Smoking damages the entire respiratory epithelium and thus “field cancerization” or “field defects”(molecular changes) are observed in histologically normal lung epithelium, as well as a variety of histologic preneoplastic/premalignant lesions, which also harbor molecular abnormalities common to the adjacent tumor5. The culmination of these changes leads to lung cancers exhibiting all the “hallmarks of cancer”(including self-sufficiency of growth signals, insensitivity to growth-inhibitory (anti-growth) signals, evasion of programmed cell death (apoptosis), limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis) 6, 7. Lung cancer is a heterogeneous disease clinically, biologically, histologically and molecularly. Understanding the molecular causes of this heterogeneity is the focus of current research and these could reflect changes occurring in different classes of epithelial cells or different molecular changes occurring in the same target lung epithelial cells. Identifying the genes and pathways involved, determining how they relate to the biologic behavior of lung cancer and their utility as diagnostic and therapeutic targets are important basic and translational research issues. Thus, current information on the key molecular steps in lung cancer pathogenesis and their timing in preneoplasia, primary cancer, and metastatic disease and the clinical implications is the subject of this review.
登录
查看更多内容
影响因子:
3.5
作者:
Baylin, SB;Esteller, M;Herman, JG
通讯作者:
Herman, JG
影响因子:
30.8
作者:
Bass, Adam J.;Watanabe, Hideo;Mermel, Craig H.;Yu, Soyoung;Perner, Sven;Verhaak, Roel G.;Kim, So Young;Wardwell, Leslie;Tamayo, Pablo;Gat-Viks, Irit;Ramos, Alex H.;Woo, Michele S.;Weir, Barbara A.;Getz, Gad;Beroukhim, Rameen;O'Kelly, Michael;Dutt, Amit;Rozenblatt-Rosen, Orit;Dziunycz, Piotr;Komisarof, Justin;Chirieac, Lucian R.;LaFargue, Christopher J.;Scheble, Veit;Wilbertz, Theresia;Ma, Changqing;Rao, Shilpa;Nakagawa, Hiroshi;Stairs, Douglas B.;Lin, Lin;Giordano, Thomas J.;Wagner, Patrick;Minna, John D.;Gazdar, Adi F.;Zhu, Chang Qi;Brose, Marcia S.;Cecconello, Ivan;Ribeiro, Ulysses, Jr.;Marie, Suely K.;Dahl, Olav;Shivdasani, Ramesh A.;Tsao, Ming-Sound;Rubin, Mark A.;Wong, Kwok K.;Regev, Aviv;Hahn, William C.;Beer, David G.;Rustgi, Anil K.;Meyerson, Matthew
通讯作者:
Meyerson, Matthew
DOI:
10.1016/s1357-2725(97)00007-1
发表时间:
1997-12-01
影响因子:
4
作者:
Bingle, CD
通讯作者:
Bingle, CD
影响因子:
11.2
作者:
Broderick P;Wang Y;Vijayakrishnan J;Matakidou A;Spitz MR;Eisen T;Amos CI;Houlston RS
通讯作者:
Houlston RS
DOI:
10.1073/pnas.0710370104
发表时间:
2007-12-26
影响因子:
11.1
作者:
Bean, James;Brennan, Cameron;Pao, William
通讯作者:
Pao, William